In yesterday’s Wall Street session, Hims & Hers Health Inc (NYSE:HIMS) shares traded at $26.20, down -0.61% from the previous session.
HIMS stock price is now 2.54% away from the 50-day moving average and 36.06% away from the 200-day moving average. The market capitalization of the company currently stands at $5.69B.
With the price target of $42, Morgan Stanley recently initiated with Overweight rating for Hims & Hers Health Inc (NYSE: HIMS). , while ‘Needham’ rates the stock as ‘Buy’
In other news, Oluyemi Okupe, Officer bought 69,496 shares of the company’s stock on Dec 20 ’24. The stock was bought for $1,820,795 at an average price of $26.20. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 19 ’24, Officer Chi Michael bought 7,500 shares of the business’s stock. A total of $195,000 was incurred on buying the stock at an average price of $26.00. A total of 18.71% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.09 and a high of $35.02. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $25.5508 and a two-hundred day moving average price translates $19.2561 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent.
